197 related articles for article (PubMed ID: 28928900)
21. Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.
Singh A; Maqbool M; Mobashir M; Hoda N
Eur J Med Chem; 2017 Jan; 125():640-651. PubMed ID: 27721149
[TBL] [Abstract][Full Text] [Related]
22. Drosophila melanogaster dihydroorotate dehydrogenase: the N-terminus is important for biological function in vivo but not for catalytic properties in vitro.
Löffler M; Knecht W; Rawls J; Ullrich A; Dietz C
Insect Biochem Mol Biol; 2002 Sep; 32(9):1159-69. PubMed ID: 12213251
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition.
Madak JT; Cuthbertson CR; Chen W; Showalter HD; Neamati N
Chemistry; 2017 Oct; 23(56):13875-13878. PubMed ID: 28833638
[TBL] [Abstract][Full Text] [Related]
24. Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH).
Lucas-Hourani M; Munier-Lehmann H; El Mazouni F; Malmquist NA; Harpon J; Coutant EP; Guillou S; Helynck O; Noel A; Scherf A; Phillips MA; Tangy F; Vidalain PO; Janin YL
J Med Chem; 2015 Jul; 58(14):5579-98. PubMed ID: 26079043
[TBL] [Abstract][Full Text] [Related]
25. The Role of Dihydroorotate Dehydrogenase in Apoptosis Induction in Response to Inhibition of the Mitochondrial Respiratory Chain Complex III.
Khutornenko AA; Dalina AA; Chernyak BV; Chumakov PM; Evstafieva AG
Acta Naturae; 2014 Jan; 6(1):69-75. PubMed ID: 24772329
[TBL] [Abstract][Full Text] [Related]
26. Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth.
Kawatani M; Aono H; Shimizu T; Ohkura S; Hiranuma S; Muroi M; Ogawa N; Ohishi T; Ohba SI; Kawada M; Yamazaki K; Dan S; Osada H
ACS Chem Biol; 2021 Nov; 16(11):2570-2580. PubMed ID: 34730931
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells.
Bajzikova M; Kovarova J; Coelho AR; Boukalova S; Oh S; Rohlenova K; Svec D; Hubackova S; Endaya B; Judasova K; Bezawork-Geleta A; Kluckova K; Chatre L; Zobalova R; Novakova A; Vanova K; Ezrova Z; Maghzal GJ; Magalhaes Novais S; Olsinova M; Krobova L; An YJ; Davidova E; Nahacka Z; Sobol M; Cunha-Oliveira T; Sandoval-Acuña C; Strnad H; Zhang T; Huynh T; Serafim TL; Hozak P; Sardao VA; Koopman WJH; Ricchetti M; Oliveira PJ; Kolar F; Kubista M; Truksa J; Dvorakova-Hortova K; Pacak K; Gurlich R; Stocker R; Zhou Y; Berridge MV; Park S; Dong L; Rohlena J; Neuzil J
Cell Metab; 2019 Feb; 29(2):399-416.e10. PubMed ID: 30449682
[TBL] [Abstract][Full Text] [Related]
28. Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides.
Löffler M; Jöckel J; Schuster G; Becker C
Mol Cell Biochem; 1997 Sep; 174(1-2):125-9. PubMed ID: 9309676
[TBL] [Abstract][Full Text] [Related]
29. Dihydroorotate dehydrogenase depletion hampers mitochondrial function and osteogenic differentiation in osteoblasts.
Fang J; Yamaza H; Uchiumi T; Hoshino Y; Masuda K; Hirofuji Y; Wagener FA; Kang D; Nonaka K
Eur J Oral Sci; 2016 Jun; 124(3):241-5. PubMed ID: 27086500
[TBL] [Abstract][Full Text] [Related]
30. Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.
Hurt DE; Sutton AE; Clardy J
Bioorg Med Chem Lett; 2006 Mar; 16(6):1610-5. PubMed ID: 16406782
[TBL] [Abstract][Full Text] [Related]
31. The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors.
Cuthbertson CR; Guo H; Kyani A; Madak JT; Arabzada Z; Neamati N
ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1242-1252. PubMed ID: 33344900
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial DHODH regulates hypoxia-inducible factor 1 expression in OTSCC.
Gao W; Hu L; Zhang M; Liu S; Xu S; Chow VL; Chan JY; Wong TS
Am J Cancer Res; 2022; 12(1):48-67. PubMed ID: 35141004
[TBL] [Abstract][Full Text] [Related]
33. Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia.
Branstrom A; Cao L; Furia B; Trotta C; Santaguida M; Graci JD; Colacino JM; Ray B; Li W; Sheedy J; Mollin A; Yeh S; Kong R; Sheridan R; Baird JD; O'Keefe K; Spiegel R; Goodwin E; Keating S; Weetall M
Front Oncol; 2022; 12():832816. PubMed ID: 35223511
[TBL] [Abstract][Full Text] [Related]
34. The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites.
Walse B; Dufe VT; Svensson B; Fritzson I; Dahlberg L; Khairoullina A; Wellmar U; Al-Karadaghi S
Biochemistry; 2008 Aug; 47(34):8929-36. PubMed ID: 18672895
[TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of recombinant dihydroorotate dehydrogenase from the opportunistic pathogenic yeast Candida albicans.
Zameitat E; Gojković Z; Knecht W; Piskur J; Löffler M
FEBS J; 2006 Jul; 273(14):3183-91. PubMed ID: 16774642
[TBL] [Abstract][Full Text] [Related]
36. Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy.
Lolli ML; Sainas S; Pippione AC; Giorgis M; Boschi D; Dosio F
Recent Pat Anticancer Drug Discov; 2018; 13(1):86-105. PubMed ID: 29119937
[TBL] [Abstract][Full Text] [Related]
37. The emergence of dihydroorotate dehydrogenase (DHODH) as a therapeutic target in acute myeloid leukemia.
Sykes DB
Expert Opin Ther Targets; 2018 Nov; 22(11):893-898. PubMed ID: 30318938
[No Abstract] [Full Text] [Related]
38. Brequinar inhibits enterovirus replication by targeting biosynthesis pathway of pyrimidines.
Fu H; Zhang Z; Dai Y; Liu S; Fu E
Am J Transl Res; 2020; 12(12):8247-8255. PubMed ID: 33437396
[TBL] [Abstract][Full Text] [Related]
39. Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification.
Al-Akashi Z; Zujur D; Kamiya D; Kato T; Kondo T; Ikeya M
Front Cell Dev Biol; 2023; 11():1089945. PubMed ID: 36814599
[TBL] [Abstract][Full Text] [Related]
40. A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells.
Kamli H; Zaman GS; Shaikh A; Mobarki AA; Rajagopalan P
Oncol Res; 2022 Jan; 28(9):899-911. PubMed ID: 34353411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
